CORRETTA BARNES: Open Payments
NPI 1568071504 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 26 payments from 10 companies in 2025. Trend: 2023 $81 · 2024 $431 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| PFIZER INC. | 5 | $99 |
| Corcept Therapeutics | 2 | $68 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Verona Pharma, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: BREZTRI, Korlym, VYNDAQEL, AIRSUPRA, TRELEGY ELLIPTA, VOQUEZNA, PREVNAR 20, OTEZLA.
Industry payments across TX — which companies pay providers there.
